Pathological and therapeutic implications of macromolecule passage through the tight junction

Tight Junctions

Volumn , Issue , 2001, Pages 697-722

  Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878086063     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038538     Document Type: Chapter

References (96)

1. Adjei, A. and Garren, J. 1992. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy human volunteers, Pharm. Res., 7, 565.
2. Adjei, A., Sundberg, D., Miller, J., and Chun, A. 1992. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans, Pharm. Res., 9, 244.
3. Artmann, C., Roding, J., Ghyczy, M., and Prazel, H. G. 1990. Liposomes from soya phospholipids as percutaneous drug carriers, Arzneim. Forsch. Drug Res., 40, 1363.
4. Baudry, B., Fasano, A., Ketley, J., and Kaper, J. B. 1991. Cloning of a gene (ZOT) encoding a new toxin produced by Vibrio cholerae, Infect. Immun., 60, 428.
5. Begley, D. J. 1996. The blood-brain barrier. Principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol., 48, 136.
6. Bjarnason, I., Peters, T. J., and Levi, J. 1986. Intestinal permeability: clinical correlates, Dig. Dis., 4, 83.
7. Bjorkman, P. J., Saper, M. A., Samraoui, B., et al. 1987. The foreign antigen binding site and T-cell recognition regions of class I immunohistocompatibility antigens, Nature, 329, 512.
8. Brandtzaeg, P., Halstensen, T. S., Kett, K., et al. 1989. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes, Gastroenterology, 97, 1562.
9. Broman, T. 1964. Blood-brain barrier damage in multiple sclerosis: supravital test observations, Acta Neurol. Scand., 21.
10. Brosnan, C. F. and Claudio, L. 1998. Brain microvaculature in multiple sclerosis, in Introduction to the Blood-Brain Barrier, Methodology, Biology and Pathology, Partridge, W. M., Ed., Cambridge University Press, London, chap. 42.
11. Carratù, R., Secondulfo, M., de Magistris, L., Iafusco, D., Urio, A., Carbone, M. G., Pontoni, G., Cartenì, M., and Prisco, F. 1999. Altered intestinal permeability to mannitol in diabetes mellitus type I, J. Pediatr. Gastroenterol. Nutr., 28, 264.
12. Casaks, J. L., González, J., López, J. M., et al. 1990. Estudio de la permeabilidad intestinal en pacientes con espondilitis anquilosante, efecto de la indometacina, Rev. Rheum., 57, 29.
13. Catassi, C., Ratsch, I., Fabiani, E., et al. 1995. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies, Acta Paediatr., 84, 672.
14. Cereijido, M. 1992. Evolution of ideas on the tight junction, in Tight Junction, CRC Press, Boca Raton, FL, 1.
15. Citi, S. 1992. Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells, J. Cell Biol., 117, 169.
16. Collin, P., Salmi, J., and Hallstrom, O. 1989. High frequency of coeliac disease in adult patients with type 1 diabetes, Scand. J. Gastroenterol., 24, 81.
17. Compston, D. A. S. 1990. The dissemination of multiple sclerosis, J. R. Coll. Phys., 24, 207.
18. Cooper, B. T., Ukabam, S. O., O’Brein, A. D., Hare, J. P. O., and Corrall, R. J. M. 1987. Intestinal permeabilty in diabetic diarrhoea, Diabetes Med., 4, 49.
19. Coppo, R., Rocatello, D., Amore, A., Quattrocchio, G., Molino, A., Gianoglio, B., Amoroso, A., Bajardi, P., and Piccoli, G. 1990. Effects of a gluten-free diet in primary IgA nephropathy, Clin. Nephrol., 33, 72.
20. Cuvelier, C., Barbatis, C., Mielants, H., et al. 1987. Histopathology of intestinal inflammation related to reactive arthritis, Gut, 28, 394.
21. Davie, C. A., Hawkins, C. P., Barker, G. J., et al. 1994. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis, Brain, 117, 49.
22. 51Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgAassociated nephropathies, Acta Paediatr. Scand., 77, 118.
23. Diamond, J. M. 1977. The epithelial junction: bridge, gate and fence, Physiologist, 20, 10.
24. Di Pierro, M., Lu, R., Uzzau, S., Wang, W., Margaretten, K., Maimone, F., and Fasano, A. 2001. Zonulin occludens toxin structure-function analysis: identification of active fragments and the receptor binding domain, J. Biol. Chem., in press.
25. Di Tommaso, A., Uzzau, S., Fasano, A., and De Magistris, M. T. 1999. Zonula occludens toxin (ZOT) acts as a mucosal adjuvant for intranasally delivered antigens, Infect. Immun., 67, 1287.
26. Dodane, V., Khan, M. A., and Merwin, J. R. 1999. Effect of chitosan on epithelial permeability and structure, Intern. J. Pharm., 182, 21.
27. du Pleiss, J., Egbaria, K., Ramachandran, C., and Weiner, N. 1992. Topical delivery of liposomally encapsulated gamma-interferon, Antiviral Res., 18, 259.
28. El Asmar, R., Panigrahi, P., Bamford, P., Berti, I., Not, T., Catassi, C., Coppa, G. V., and Fasano, A. 2000. Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization, Pediatr. Res., 47, 960.
29. Ellenberg, M. 1963. Diabetic enteropathy, Am. J. Gastroenterol., 40, 269.
30. Emancipator, S. N. 1994. IgA nephropathy: morphologic expression and pathogenesis, Am. J. Kidney Dis., 23, 451.
31. Emancipator, S. N. and Lamm, M. E. 1989. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis, Lab. Invest., 60, 168.
32. Fasano, A. 1998. Innovative strategies for the oral delivery of drugs and macromolecules, Trends Biotech., 16, 152.
33. Fasano, A. 1998. Novel approaches for oral delivery of macromolecules, J. Pharmacol. Sci., 11, 1351.
34. Fasano, A., 2000. Regulation of intercellular tight junctions by zonula occludens toxin (Zot) and its eukaryotic analogue zonulin, Ann. N.Y. Acad. Sci., 95, 214.
35. Fasano, A. and Uzzau, S. 1997. Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model, J. Clin. Invest., 99, 1158.
36. Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. M., and Kaper, J. B. 1991. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions, Proc. Natl. Acad. Sci. U.S.A., 88, 5242.
37. Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., and Goldblum, S. E. 1995. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro, J. Clin. Invest., 96, 710.
38. Fasano, A., Uzzau, S., Fiore, C., and Margaretten, K. 1997. The enterotoxic effect of zonula occludens toxin (Zot) on rabbit small intestine involves the paracellular pathway, Gastroenterology, 112, 839.
39. Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, T., and Goldblum, S. E. 2000. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease, Lancet, 358, 1518.
40. Feldman, M. and Schiller, L. R. 1983. Disorders of gastrointestinal motility associated with diabetes mellitus, Ann. Intern. Med., 98, 378.
41. Freehally, J. 1988. Immune mechanism in glomerular IgA deposition, Nephrol. Dialysis Transplant., 3, 361.
42. Gilula, N. B., Fawcett, D. W., and Aoki, A. 1976. The sertoli cell occluding junctions and gap junctions in mature and developing mammalian testis, Dev Biol, 50, 142.
43. Gumerlock, M. K. 1992. in Physiology and Pharmacology of the Blood-Brain Barrier, Gumerlock, M. K. and Neuwelt, E. A., Eds., M. W. B. Bradbury, Springer, Berlin, 525.
44. Hin, H., Bird, G., Fisher, P., Mahy, N., and Jewell, D. 1999. Coeliac disease in primary care: case finding study, Br. Med. J., 318, 164.
45. Hochman, J. and Artursson, P. 1994. Mechanisms of absorption enhancement and tight junction regulation, J. Controlled Release, 29, 253.
46. Hollander, D., Vadheim, C. M., Brettholz, E., Petersen, G. M., Delahunty, T., and Rotter, J. I. 1986. Increased intestinal permeability in patients with Crohn’s disease and their relatives, Ann. Intern. Med., 105, 883.
47. Isolauri, E., Kaila, M., Arvola, T., Majamaa, H., Rantala, I., Virtanen, E., and Arvilommi, H. 1986. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats, Pediatr. Res., 33, 548.
48. Kermode, A. G., Thompson, A. J., Tofts, P., MacManus, D. G., Kendall, B. E., Kingsley, D. P., Moseley, I. F., Rudge, P., and McDonald, W. I. 1990. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis, Brain, 113, 1477.
49. Kovacs, T., Kun, L., Schmelczer, M., Wagner, L., Davin, J. C., and Nagy, J. 1996. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability, Am. J. Nephrol., 16, 500.
50. Lee, V. H. L., Yamamoto, A., and Kompella, V. B. 1991. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption, Crit. Rev. Ther. Drug Carrier Syst., 8, 91.
51. Leone-Bay, A., Paton, D. R., and Weidner, J. J. 2000. The development of delivery agents that facilitate the oral absorption of macromolecular drugs, Med. Res. Rev., 20, 169.
52. Lu, R., Wang, W., Uzzau, S., Vigorito, R., Zielke, R. H., and Fasano, A. 2000. Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain, J. Neurochem., 74, 320.
53. Madara, J. L. 1989. Loosening tight functions lessons from the intestine, J. Clin. Invest., 83, 1089.
54. Madara, J. L. and Pappenheimer, J. R. 1987. Structural basis for physiological regulations of paracellular pathways in intestinal epithelia, J. Membr. Biol., 100, 149.
55. Madara, J. L. and Trier, J. S. 1980. Structural abnormalities of jejunal epithelial cell membranes in celiac sprue, Lab. Invest., 43, 254.
56. Magnuson, T., Jacobson, J. B., and Stackpole, C. W. 1978. Relationship between intercellular permeability and junction organization in the preimplantation mouse embryo, Dev. Biol., 67, 214.
57. Maki, M., Huupponen, T., Holm, K., and Hallstrom, O. 1995. Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus, Gut, 36, 239.
58. Marcial, M. A., Carlson, S. L., and Madara, J. L. 1984. Partitioning of paracellular conductance along the ileal crypt-villus axis: a hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships, J. Membr. Biol., 80, 59.
59. Martinez-Gonzalez, O., Cantero-Hinojosa, J., Paule-Sastre, P., Gomez-Magan, J. C., and Salvtierra-Rios, D. 1994. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives, Br. J. Rheumatol., 33, 644.
60. Mazariegos, M. R., Tice, L. W., and Hand, A. R. 1984. Alteration of tight junctional permeability in the rat parotid gland after isoproteranol stimulation, J. Cell Biol., 98, 1865.
61. McNair, A. and Olsen, J. 1974. Disaccharidase activity in chronic renal failure, Acta Med. Scand., 195, 93.
62. Meddings, J. B., Jarand, J., Urbanski, S. J., Hardin, J., and Gall, D. G. 1999. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat, Am. J. Physiol., 276, G951.
63. Mielants, H., De Vos, M., Goemaere, S., Schelstraete, K., and Cuvelier, C. 1991. Intestinal mucosal permeability in inflammatory rheumatic diseases, II. Role of disease, J. Rheumatol., 18, 394.
64. Milks, L. C., Conyers, G. P., and Cramer, E. B. 1986. The effect of neutrophil migration on epithelial permeability, J. Cell Biol., 103, 2729.
65. Mooradian, A. D., Morley, J. E., Levine, A. S., Prigge, W. F., and Gebhard, R. L. 1986. Abnormal intestinal permeability to sugars in diabetes mellitus, Diabetologia, 29, 221.
66. Nagy, J., Scott, H., and Brandtzeag, P. 1988. Antibodies to dietary antigens in IgA nephropathy, Clin. Nephrol., 29, 275.
67. Nash, S., Stafford, J., and Madara, J. L. 1988. The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration, Lab. Invest., 59, 531.
68. Not, T., Horvath, K., Hill, I. D., Partanen, J., Hammed, A., Magazzu, G., and Fasano, A. 1998. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors, Scand. J. Gastroenterol., 33, 494.
69. Partridge, W. M. 1998. Introduction to the Blood-Brain Barrier, Cambridge University Press, Cambridge, UK.
70. Prokai, L. 1998. Peptide drug delivery into the central nervous system, Prog. Drug Res., 51, 95.
71. Revel, J. P. and Brown, S. S. 1976. Cell junctions in development with particular reference to the neural tube, Cold Spring Harbor Symp. Quant. Biol., 40, 443.
72. Rostoker, G., Wirquin, V., Terzidis, H., Petit-Phar, M., Chaumette, M. T., Delchier, J. C., Belghitis, D., Lang, P., Dubert, J. M., Meignan, M., Lagrue, G., and Weil, B. 1993. Mucosal immunity in primary glomerulonephritis, III. Study of intestinal permeability, Nephron, 63, 286.
73. Sardet, C., Pisam, M., and Maetz, J. 1979. The surface epithelium of teleostean fish gills: cellular and junctional adaptations of the chloride cell in relation to salt adaptation, J. Cell Biol., 80, 96.
74. Sayani, A. P. and Chien, Y. W. 1996. Systemic delivery of peptides and proteins across absorptive mucosae, Crit. Rev. Ther. Drug Carrier Syst., 13, 85.
75. Schmitz, H., Barmeyer, C., Fromm, M., Runkel, N., Foss, H. D., Bentzel, C. J., Riecken, E. O., and Schulzke, J. D. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis, Gastroenterology, 116, 301.
76. Schneeberger, E. E., Walters, D. V., and Olver, R. E. 1978. Development of intercellular junctions in the pulmonary epithelium of the foetal lamb, J. Cell Sci., 32, 307.
77. Schulzke, J. D., Bentzel, C. J., Schulzke, I., Riecken, E. O., and Fromm, M. 1998. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue, Pediatr. Res., 43, 435.
78. Selmaj, K., Raine, C. S., Cannella, B., and Brosnan, C. F. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J. Clin. Invest., 87, 949.
79. Shasby, D. M., Winter, M., and Shasby, S. S. 1988. Oxidants and conductance of cultured epithelial cell monolayers: inositol phospholipid hydrolysis, Am. J. Physiol., 255, 24, C781.
80. Smith, M. D., Gibson, R. A., and Brooks, P. M. 1985. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis, J. Rheumatol., 12, 299.
81. Sollid, L. and Thorsby, E. 1993. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis, Gastroenterology, 105, 910.
82. Sterner, G., Asp, N., Dahlquist, A., Denneberg, T., and Lindberg, T. 1980. Small intestinal dipeptidases and disaccharidases in experimental uremia in rats, Nephron, 26, 149.
83. Thanou, M. M., Kotzé, A. F., Scharringhausen, T., Luessen, H. L., de Boer, A. G., Verhoef, J. C., and Junginger, H. E. 2000. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers, J. Controlled Release, 64, 15.
84. Uzzau, S., Cappuccinelli, P., and Fasano, A. 1999. Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization, Microb. Pathog., 27, 377.
85. Uzzau, S., Lu, R., Wang, W., Fiore, C., and Fasano, A. 2001. Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines, FEMS.
86. Vaile, J. H., Meddings, J. B., Yacyshyn, B. R., Russell, A. S., and Maksymowych, W. P. 1999. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives, J. Rheumatol., 26, 128.
87. Ventura, A., Magazzu, G., and Greco, L. 1999. Duration of exposure to gluten and risk for autoimmune disorders in celiac patients, Gastroenterology, 117, 303.
88. Wang, W., Uzzau, S., Goldblum, S. E., and Fasano, A. 2000. Human zonulin, a potential modulator of intestinal tight junctions, J. Cell Sci., 24, 4435.
89. Watts, T. L., Alexander, T., Hansen, B., and Fasano, A. 2000a. Utilizing the paracellular pathway: a novel approach for the delivery of oral insulin in diabetic rhesus macaques, J. Invest. Med., 48, 185.
90. Watts, T., Not, T., Berti, I., El Asmar, R., Di Pierro, M., Margaretten, K., and Fasano, A. 2000b. Alterations in zonulin secretion parallels changes in intestinal permeability and precede the onset of diabetes in BB/Wor diabetic rats, J. Invest. Med., 48, 184.
91. 51Cr-EDTA, Rev. Esp. Reumatol., 19, 253.
92. Williams, D. G. 1993. Pathogenesis of idiopathic IgA nephropathy, Pediatr. Nephrol., 7, 303.
93. Yacyshyn, B. R. and Meddings, J. B. 1995. CD45RO expression on circulating CD19+ B cells in Crohn’s disease correlates with intestinal permeability, Gastroenterology, 108, 132.
94. Yacyshyn, B. R. and Pilarski, L. M. 1993. Expression of CD45RO on circulating CD19+ B-cells in Crohn’s disease, Gut, 34, 1698.
95. Yacyshyn, B., Meddings, J., Sadowski, D., and Bowen-Yacyshyn, M. B. 1996. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability, Dig. Dis. Sci., 41, 2493.
96. Yu, J. and Chien, Y. W. 1997. Pulmonary drug delivery: physiologic and mechanistic aspects, Crit. Rev. Ther. Drug Carrier Syst., 14, 395.